VPS13A Gene Choreoacanthocytosis NGS Genetic DNA Test
Introduction to the VPS13A Gene Choreoacanthocytosis Test
The VPS13A Gene Choreoacanthocytosis NGS Genetic DNA Test is a cutting-edge diagnostic tool that leverages Next-Generation Sequencing (NGS) technology to identify mutations in the VPS13A gene. This genetic test is essential for diagnosing Choreoacanthocytosis, a rare neurological disorder characterized by movement disorders and other neurological symptoms. Early detection through this test can lead to timely interventions and better management of the condition.
What the Test Measures
This test specifically measures genetic variations in the VPS13A gene, which are known to contribute to the development of Choreoacanthocytosis. By analyzing the DNA, healthcare professionals can determine whether an individual carries mutations that may predispose them to this disorder.
Who Should Consider This Test?
Individuals who experience symptoms such as involuntary movements, cognitive decline, or have a family history of neurological disorders should consider this test. Risk factors include:
- Family history of Choreoacanthocytosis
- Presence of neurological symptoms
- Genetic predisposition to related disorders
Benefits of Taking the Test
- Early diagnosis of Choreoacanthocytosis, leading to timely treatment.
- Informed family planning and genetic counseling.
- Better understanding of personal health risks associated with VPS13A gene mutations.
Understanding Your Results
Results from the VPS13A Gene Choreoacanthocytosis test will indicate whether mutations are present in the VPS13A gene. A genetic counseling session is recommended to interpret the results accurately and discuss potential implications for the individual and their family.
Test Details and Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| VPS13A Gene Choreoacanthocytosis NGS Genetic DNA Test | 400,000 NGN | 560,000 NGN |
How to Book the Test
To book the VPS13A Gene Choreoacanthocytosis NGS Genetic DNA Test, please contact us at +2348077798758. Our team is ready to assist you with scheduling and answering any questions you may have about the test.
Additional Information
Turnaround time for results is approximately 3 to 4 weeks. The sample required for this test can be blood or extracted DNA, or even one drop of blood on an FTA card. Prior to the test, it is essential to provide a clinical history and undergo a genetic counseling session to create a pedigree chart of family members affected by VPS13A Gene Choreoacanthocytosis.
